Evidence map›Paper›PMID 18784312›Full record

ArticleJournal of clinical microbiology2008

Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay.

J L Guthrie, C Seah, S Brown, P Tang, F Jamieson, S J Drews

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  8. Article
  9. Should equivocalCanada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Effectiveness of pertussis vaccination and duration of immunity.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Article
  14. Article
  15. Article
  16. Laboratory Diagnosis of Pertussis.Clinical microbiology reviews · 2015
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J L GuthrieMinistry of Health and Long-Term Care, 81 Resources Rd., Toronto, Ontario M9P 3T1, Canada. jennifer.guthrie@ontario.ca
C Seah
S Brown
P Tang
F Jamieson
S J Drews

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study utilized the Bordetella pertussis single-copy PCR target BP3385 as a means of confirming IS481 PCR-positive reactions with cycle threshold (C(T)) values of >35. IS481 PCRs with C(T) values of >35 cycles may represent PCR conditions where there is <1 CFU of B. pertussis per PCR.

Indexed as

DNA Transposable ElementsBacterial ProteinsBordetella pertussisHumansMolecular Sequence DataPolymerase Chain ReactionSensitivity and SpecificityWhooping CoughBacterial ProteinsDNA Transposable Elements

Identifiers

PMID18784312
PMCPMC2576621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.